RIP to These 3 Dying Medical Stocks Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before… Previous Article 3 Reasons Online Marketplaces Benefit Entrepreneurs — and Should Be Protected Next Article Don't Underestimate the Power of Company Culture. It's Still as Important as Ever.
